Literature DB >> 7507593

Effect of recombinant human colony-stimulating factor on the course of parasitaemia in non-lethal rodent malaria.

S Waki1, R Kurihara, H Nemoto, M Suzuki.   

Abstract

The effect of repeated subcutaneous injections of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on the attenuated Plasmodium berghei XAT infection in CBA mice was examined. When mice were injected with rhG-CSF daily beginning 2 days before infection, the neutrophil count in the peripheral blood increased 5 times higher than that of control mice and the development of parasitaemia was suppressed significantly during the early phase of the infection. This suppressive effect of rhG-CSF was reduced by treatment of the mice with either anti-interferon (IFN)-gamma or anti-tumour necrosis factor (TNF)-alpha immunoglobulins. These results suggest that neutrophils may have a role in immunity against the parasites and that IFN-gamma and TNF-alpha are possibly involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507593     DOI: 10.1007/bf00932515

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  10 in total

1.  Plasmodium berghei: isolation and maintenance of an irradiation attenuated strain in the nude mouse.

Authors:  S Waki; J Tamura; M Imanaka; S Ishikawa; M Suzuki
Journal:  Exp Parasitol       Date:  1982-06       Impact factor: 2.011

2.  Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages).

Authors:  A Ferrante; L Kumaratilake; C M Rzepczyk; J M Dayer
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

3.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

4.  Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages.

Authors:  C F Ockenhouse; S Schulman; H L Shear
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

5.  The role of T cells in pathogenesis and protective immunity to murine malaria.

Authors:  S Waki; S Uehara; K Kanbe; K Ono; M Suzuki; H Nariuchi
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

6.  Immunity to an attenuated variant of Plasmodium berghei: role of some non-specific factors.

Authors:  S Waki; S Nakazawa; J Taverne; G A Targett; J H Playfair
Journal:  Parasitology       Date:  1985-10       Impact factor: 3.234

7.  Effect of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on murine resistance against Listeria monocytogenes.

Authors:  B A Serushago; Y Yoshikai; T Handa; M Mitsuyama; K Muramori; K Nomoto
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

8.  The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects.

Authors:  L M Kumaratilake; A Ferrante; C Rzepczyk
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

9.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Authors:  M R Shalaby; B B Aggarwal; E Rinderknecht; L P Svedersky; B S Finkle; M A Palladino
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF).

Authors:  M Tamura; K Hattori; H Nomura; M Oheda; N Kubota; I Imazeki; M Ono; Y Ueyama; S Nagata; N Shirafuji
Journal:  Biochem Biophys Res Commun       Date:  1987-01-30       Impact factor: 3.575

  10 in total
  1 in total

1.  Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease.

Authors:  Chandy C John; Gregory S Park; Nadia Sam-Agudu; Robert O Opoka; Michael J Boivin
Journal:  Cytokine       Date:  2008-02-20       Impact factor: 3.861

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.